Senior insider sale
Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. — senior position signals high conviction
$223.9K
24K shares
What this filing means
THOMPSON RAHSAAN plans to sell 24K shares of ZEVRA THERAPEUTICS, INC. valued at approximately $223.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2025ACC: 0001950047-25-004639
OfficerOther· Chief Legal & Compliance
Since Jan 2026
24K
Shares to sell
$223.9K
Approx. market value
24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/21/2025
24KTotal acquired24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/21/2025 | Restricted Stock Units N/A | 24K | — |
| Total | 24K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
24K
Market value
$223.9K
6/26/2025
Total
Units
24K
Value
$223.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2025 | 24K | $223.9K | NASDAQ | Planned |
| Total | 24K | $223.9K | ||